Francesco Parisi

Francesco Parisi

Auto-generated profile, based on publicly available information

Francesco Parisi

Thoracic Transplant and Pulmonary Hypertension Unit, Bambino Ges u Children Hospital, Roma, Italy

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Transplantation
Verified
Journal Article
Closed access
ALAndrea Lamioni
Andrea Lamioni
FPFrancesco Parisi
Francesco Parisi
GIGiancarlo Isacchi
Giancarlo Isacchi
EGEzio Giorda
Ezio Giorda
SCSILVA DI CESARE
SILVA DI CESARE
RCRita Carsetti
Rita Carsetti
Extracorporeal photopheresis (ECP) may represent an alternative to immunosuppression, as a means of reducing rejection after thoracic organ transplantation. The mechanism by which ECP exerts its protective effects has, until now, remained elusive. We analyzed peripheral blood mononuclear cells of four children with chronic heart and lung transplant rejection, who received ECP in addition to conventional immunosuppressive treatment. The effects of ECP were evaluated at each cycle, comparing blood samples from the same patient collected before and after treatment. In vitro, peripheral blood mononuclear cells treated with ECP undergo apoptosis and are phagocytosed by immature dendritic cells, which, in turn, acquire a tolerogenic phenotype. The frequency of T cells, with a regulatory phenotype and strong suppressive activity, was significantly increased in the blood of ECP-treated patients. The immunomodulatory effects of ECP may be explained by its ability to increase the frequency of regulatory T cells with inhibitory action on transplant immune rejection.

1 May 2001 in JACC
Verified
Journal Article
Closed access
Roberto FormigariRoberto Formigari
Roberto Formigari
RDRoberto M Di Donato
Roberto M Di Donato
EMEnnio Mazzera
Ennio Mazzera
ACAdriano Carotti
Adriano Carotti
GRGabriele Rinelli
Gabriele Rinelli
LBLuigi Ballerini
Luigi Ballerini

1 August 2004 in The Journal of Pediatrics
Verified
Journal Article
Closed access
FSFrancesca Santamaria
Francesca Santamaria
GBGianluca Brancaccio
Gianluca Brancaccio
GPGiancarlo Parenti
Giancarlo Parenti
PFPaola Francalanci
Paola Francalanci
CSCosimo Squitieri
Cosimo Squitieri
FPFrancesco Parisi
Francesco Parisi

1 October 2003 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
GMGuido Michielon
Guido Michielon
FPFrancesco Parisi
Francesco Parisi
DCDuccio Di Carlo
Duccio Di Carlo
CSCosimo Squitieri
Cosimo Squitieri
ACAdriano Carotti
Adriano Carotti
RDRoberto M. Di Donato
Roberto M. Di Donato
Evaluation of incremental risk factors for early mortality in children undergoing orthotopic heart transplantation (OHT) for failing single ventricle physiology. Between 1988 and 2002, 25 patients (mean age 9.3+/-7.1 years) underwent OHT for complex congenital heart disease (CHD) with a functional right (15 patients) or left (10 patients) single ventricle. Palliative staging towards Fontan completion had been previously accomplished in 22 patients (88%). Transition to OHT occurred from a shunt stage in 10, a bi-directional cavopulmonary anastomosis (BDG) stage in nine, and after Fontan failure in six patients. Thirty-day survival was 68.0+/-9.3% with no additional mortality up to 14.1 years. OHT following BDG staging exhibited 100% long-term survival, as opposed to 66.7+/-15.7% for OHT after systemic-to-pulmonary shunt, and 33.3+/-19.2% for OHT following failing Fontan (p=0.032). Regression logistic modelling indicated failing Fontan circulation as predictor of higher mortality after OHT (p=0.041). Reintervention was necessary in four patients 40+/-11 months after OHT to address residual superior vena cava (two) and isthmic (two) stenosis. Overall freedom from reintervention was 88.3+/-8.1% at 5 years. OHT for structural CHD with single ventricle physiology entails substantial early mortality while BDG enables the best transition to heart transplant. OHT should be considered in the decision-making process as an alternative to Fontan completion in high-risk candidates, since rescue-OHT after failing Fontan seems unwarranted.

1 April 2003 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
PDF file
GBGianluca Brancaccio
Gianluca Brancaccio
ACAdriano Carotti
Adriano Carotti
PDPatrizia D’argenio
Patrizia D’argenio
GMGuido Michielon
Guido Michielon
FPFrancesco Parisi
Francesco Parisi

1 December 2001 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
EPEnrica Pastore
Enrica Pastore
ATAttilio Turchetta
Attilio Turchetta
LALeonello Attias
Leonello Attias
ACArmando Calzolari
Armando Calzolari
UGUgo Giordano
Ugo Giordano
FPFrancesco Parisi
Francesco Parisi